The future may be physiologic, but today’s hormone decisions still matter Bioengineered ovaries are an emerging research path, not a current treatment option. The core reader question usually comes down to whether current…
Weight loss should protect more than the number on the scale The real question is not only how much weight comes off, but how much strength-supporting tissue stays in place. Combination therapies like…
A one-shot obesity therapy sounds compelling, but the real question is what can be acted on now RJVA-002 is still preclinical, so it belongs to the research pipeline rather than today’s treatment menu.…
A monthly obesity drug is exciting, but the better question is what helps weight loss stay workable MariTide’s once-monthly schedule is compelling because convenience often shapes long-term adherence as much as efficacy. Durability…